BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B

Thiabendazole

a variety of nematodes and is the drug of choice for STRONGYLOIDIASIS. It has CENTRAL NERVOUS SYSTEM side effects and hepatototoxic potential. (From Smith and Reynard, Textbook of Pharmacology, 1992, p919)

299+ PubMed studies analyzed · 8 RCTs · Evidence Score: 40.8

Research Domains

Thiabendazole has been studied across 13 research domains including 🫁 Liver & Detox, 🦠 Gut & Microbiome, 🔬 Oncology, 😴 Sleep, 🫘 Kidney. The primary research focus is 🫁 Liver & Detox with 6% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Thiabendazole, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Carboxin
11 shared targets
2-Acetylaminofluorene
12 shared targets
Leflunomide
17 shared targets
Phenelzine
12 shared targets
propyl
9 shared targets
Nitrofurazone
12 shared targets
Bromodeoxyuridine
8 shared targets
thiophanate
8 shared targets
Melphalan
14 shared targets
Secologanin
9 shared targets
Loading evidence profile...

This evidence profile for Thiabendazole is generated deterministically from 299 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.